Minocycline: The search for a community hospital acute stroke therapy

Neurology India

Volumn 60, Issue 1, 2012, Pages 1-2

  Hess, David ^a   Howard, Virginia ^b   Howard, George ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY HOSPITAL; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; EDITORIAL; HEART DISEASE; HUMAN; HYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); STROKE PATIENT; TREATMENT OUTCOME;

FEMALE; HUMANS; MALE; MINOCYCLINE; NEUROPROTECTIVE AGENTS; STROKE;

EID: 84859168335     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.93580     Document Type: Editorial

References (9)

1. Kleindorfer D, Xu Y, Moomaw CJ, Khatri P, Adeoye O, Hornung R. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke 2009;40:3580-4.
2. Fagan SC, Cronic LE, Hess DC. Minocycline development for acute ischemic stroke. Transl Stroke Res 2011;2:202-8.
3. Padma MV, Bhasin A, Bhatia R, Garg A, Gaikwad S, Prasad K, et al. Efficacy of Minocycline in Acute Ischemic Stroke: A single-blinded, placebo-controlled trial. Neurol India 2012;60:23-8.
4. Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, et al. Minocycline treatment in acute stroke: An open-label, evaluator-blinded study. Neurology 2007;69:1404-1410.
5. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC, Jr. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301:831-41.
6. Fagan SC, Waller JL, Nichols FT, Edwards DJ, Pettigrew LC, Clark WM, et al. Minocycline to improve neurologic outcome in stroke (MINOS): A dose-finding study. Stroke 2010;41:2283-7.
7. Machado LS, Sazonova IY, Kozak A, Wiley DC, El-Remessy AB, Ergul A, et al. Minocycline and tissue-type plasminogen activator for stroke: Assessment of interaction potential. Stroke 2009;40:3028-3033.
8. Murata Y, Rosell A, Scannevin RH, Rhodes KJ, Wang X, Lo EH. Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke 2008;39:3372-7.
9. Zhao F, Hua Y, He Y, Keep RF, Xi G. Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage. Stroke 2011;42:3587-3593.